Elize Massard Da Fonseca
Biographic Data
| ID | 264275 |
|---|---|
| NAME | Elize Massard Da Fonseca |
| GIVEN NAMES | Elize Massard |
| FAMILY NAME | Da Fonseca |
| SIGNATURE | DA FONSECA E M |
| AFFILIATIONS | Fundação Getulio Vargas |
| ORCID | 0000-0003-3847-3105 |
| VERIFIED | Yes |
| TOTAL WORKS | 29 |
| TOTAL CITATIONS | 81 |
| AUTHOR COUNT | 24 |
| EDITOR COUNT | 5 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 5 |
Borrowing regulatory capacity in middle-income countries during public health crises
Strengthening regulation for medical products in Tanzania
Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania’s pharmaceutical sector is often cited as a successful example of a well-functioning regulatory system in a developing country, attributed to the work of the Tanzania Food and Drugs Authority (TFDA), now the Tanzania Medicines and Medical Devices Authority (TMDA). This raises the quest…
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the problem remains unknown. We conducted a large field survey of essential medicines in Indonesia, and investigated how weighting survey results by market volume altered estimates of medicine quality. We …
Costing the intergovernmental negotiating body (INB) process
The Intergovernmental Negotiating Body (INB) was established to draft and negotiate a pandemic instrument to strengthen pandemic preparedness and response (PPR). This has been carried out under the auspices of the World Health Organization (WHO), and has to date involved 15 sessions in Geneva, plus countless hours both in informal working groups, and in capitals working on government positions on each substantive issue. This all comes at a cost, …
Institutions and the politics of agency in Covid-19 response
The COVID-19 pandemic of 2020 was one of the rare events that shocked almost every world government simultaneously, thus creating an unusual opportunity to understand how political institutions shape policy decisions. There have been many analyses of what governments did. We focus instead on what they could do, focusing on the institutional politics of agency – how institutions empower rather than how they constrain, and how they affect public po…
What Makes Bureaucracies Politically Resilient? Evidence from Brazil’s Covid‐19 Vaccination Campaign
This article sheds new light on the drivers of bureaucratic resilience in the face of presidential attacks, an understudied but politically salient topic. Scholars have long shown how political advocacy can protect bureaucracies from presidential attacks on policy regulation. We argue, however, that advocacy is insufficient to defend bureaucracies against attacks on policy implementation, which occurs largely outside the formal political arena. T…
Real-world effectiveness of Covid-19 vaccines among Colombian adults
COVID-19 vaccines have been essential for reducing the impact of the pandemic; nevertheless, population-based data under real-life conditions are needed to compare their effectiveness in various contexts. The objective of this study was to estimate the effectiveness of vaccines in preventing hospitalization and death from COVID-19 in Colombia under real-life conditions among people aged 18 years and older, according to sex, age, confirmed history…
Provider-identified barriers to performance at seven Nigerian accident & emergency units
Background Nigeria hosts much of Africa’s morbidity and mortality from emergency medical conditions. We surveyed providers at seven Nigerian Accident & Emergency (A&E) units about (i) their unit’s ability to manage six major types of emergency medical condition (sentinel conditions) and (ii) barriers to performing key functions (signal functions) to manage sentinel conditions. Here, we present our analysis of provider-reported barriers to signal …
Dependency, Capacity, and Agency
Perspectives in the study of the political economy of Covid‐19 vaccine regulation
Vaccines against SARS‐CoV‐2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID‐19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID‐19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commerci…
Captura ou não captura? Perspectivas analíticas no estudo de políticas regulatórias
A discussão de captura regulatória não é uma agenda recente em estudos do Estado, mas o estabelecimento de critérios para identificação de captura, bem como a definição de protocolos para demonstração e mensuração do fenômeno estão longe de um consenso. O presente artigo tem por objetivo, por meio de uma revisão sistematizada não exaustiva da literatura, identificar as principais estratégias de captura e suas respectivas formas de mensuração. Pro…
Political discourse, denialism and leadership failure in Brazil’s response to Covid-19
The COVID-19 pandemic posed challenges for healthcare systems and political leaders across the globe. In this case study of Brazil, we argue that leadership failings at the highest level contributed to Brazil's relatively high and escalating death rates during 2020. Drawing on an analysis of a large amount of textual documentation drawn from media reports, we emphasise the role and consequences of President Jair Bolsonaro's political discourse an…
Social policy as an integral component of pandemic response
It is easy but mistaken to think that public health emergency measures and social policy can be separated. This paper compares the experiences of Brazil, Germany, India and the United States during their 2020 responses to the COVID-19 pandemic to show that social policies such as unemployment insurance, flat payments and short-time work are crucial to the effectiveness of non-pharmaceutical interventions as well as to their political sustainabili…
Coronavirus Politics
The politics of Covid-19 vaccination in middle-income countries
As the world struggles to meet the challenges of vaccination against COVID-19, more attention needs to be paid to issues faced by countries at different income levels. Middle-income countries (MICs) typically lack the resources and regulatory capacities to pursue strategies that wealthier countries do, but they also face different sets of challenges and opportunities than low-income countries (LICs). We focus on three dimensions of vaccination: p…
The comparative politics of Covid-19
COVID-19 has created a ramifying public health, economic, and political crisis throughout many countries in the world. While globally the pandemic is at different stages and far from under control in some countries, now is the time for public health researchers and political scientists to start understanding how and why governments responded the way they have, explore how effective these responses appear to be, and what lessons we can draw about …
Building effective collaboration between health systems and the life sciences industry
This viewpoint reflects on the challenges of promoting affordable and innovative medicines while fostering a competitive environment for research and development in developing countries. We explore the life sciences industrial policies of Brazil and the United Kingdom in order to identify mechanisms and conditions that could serve as lessons to practitioners in other countries. We suggest three crucial design attributes: a strategic collaboration…
Integrating Science, Technology and Health Policies in Brazil
Brazil has encouraged an ambitious set of policies towards the pharmaceutical industry, aiming to foster technological development while meeting health requirements. We characterise these efforts, labelled the 'Complexo Industrial da Saúde' (Health-Industry Complex, CIS), as an outcome of incremental policy change backed by the sustained efforts of public health professionals within the federal bureaucracy. As experts with a particular vision of …
How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health–industry complex in Brazil
The global health community is increasingly advocating for the local production of pharmaceuticals in developing countries as a way to promote technology transfer, capacity building and improve access to medicines. However, efforts to advance drug manufacturing in these countries revive an old dilemma of fostering technological development versus granting access to social services, such as healthcare. This paper explores the case of Brazil, a cou…
Promoting and regulating generic medicines
Promoting the use of generic drugs can constitute a core instrument for countries’ national pharmaceutical policies, one that reduces drug expenditure while expanding health care access. Despite the potential importance of such policy measures and the differences among national practices, scholars embarking on comparative analysis lack a roadmap for determining which dimensions of generic drug policy to assess and compare. This report fills that …
Pharmaceutical Autonomy and Public Health in Latin America
"Pharmaceutical Autonomy and Public Health in Latin America: State, Society, and Industry in Brazil’s AIDS Program, By M. Flynn." The Journal of Development Studies, 52(12), pp. 1826–1827
Federalism, the Economic-Industrial Health Care Complex and High-Cost Pharmaceutical Assistance in Brazil
Brazil has a relevant, although relatively unknown, special medicines programme that distributes high-cost products, such as drugs needed for cancer treatments. In 2009, the purchase of these medicines became the responsibility of the Brazilian Federal Government. Until then, there were no clear norms regarding the responsibilities, in terms of the management/financing of these medicines, of the Brazilian Federal Government and of the states them…
Health Policy as Industrial Policy
In contrast to analyses that regard health policy and industrial policy as anathema to each other, either because an emphasis on health implies neglect of industry or because gains in industrialization come at the expense of health, we show positive synergies between the two realms. Government intervention into the health sector can catalyze interventions to promote industrial development in the pharmaceutical sector, which in turn can make healt…
Allocation of authority in European health policy
State-Sponsored Activism
"State-Sponsored Activism: Bureaucrats and Social Movements in Democratic Brazil." The Journal of Development Studies, 56(7), pp. 1430–1431
Health Policy as Industrial Policy
In contrast to analyses that regard health policy and industrial policy as anathema to each other, either because an emphasis on health implies neglect of industry or because gains in industrialization come at the expense of health, we show positive synergies between the two realms. Government intervention into the health sector can catalyze interventions to promote industrial development in the pharmaceutical sector, which in turn can make healt…
The politics of Covid-19 vaccination in middle-income countries
As the world struggles to meet the challenges of vaccination against COVID-19, more attention needs to be paid to issues faced by countries at different income levels. Middle-income countries (MICs) typically lack the resources and regulatory capacities to pursue strategies that wealthier countries do, but they also face different sets of challenges and opportunities than low-income countries (LICs). We focus on three dimensions of vaccination: p…
Mobilizing Bias in Europe
What effects do interest groups have on the democratization and legitimacy of the European Union (EU)? Interest groups can democratize the EU only to the extent that they do not replicate inequalities. We use a newly constructed database to look for inequalities: Are the big organizations in Brussels the same as the ones in the EU member states? Are some member states' lobbies more active than others? And does the structure of EU lobbying create …
Descentralização, Aids e redução de danos
O artigo avalia como a descentralização dos recursos e ações do Programa Nacional de DST e AIDS influenciou as transferências de recursos para os programas de prevenção ao HIV/AIDS entre usuários de drogas injetáveis no Rio de Janeiro, Brasil (1999-2006). Foram avaliados os efeitos da política de descentralização sobre as transferências de recursos para os Programas de Redução de Danos (PRD) no Rio de Janeiro. A descentralização das transferência…
Syringe exchange programs in Brazil
The present study aims to evaluate the current operation of Brazilian syringe exchange programs (SEP). After consulting national and regional networks of people working in projects/ programs aiming to reduce drug-related harm, we identified 134 potential participant programs. Unfortunately, only 45 SEPs answered a survey, even after repeated attempts. The survey addressed: coverage, funding, procurement of basic supplies, managerial capacity, and…
Institutions and the politics of agency in Covid-19 response
The COVID-19 pandemic of 2020 was one of the rare events that shocked almost every world government simultaneously, thus creating an unusual opportunity to understand how political institutions shape policy decisions. There have been many analyses of what governments did. We focus instead on what they could do, focusing on the institutional politics of agency – how institutions empower rather than how they constrain, and how they affect public po…
What Makes Bureaucracies Politically Resilient? Evidence from Brazil’s Covid‐19 Vaccination Campaign
This article sheds new light on the drivers of bureaucratic resilience in the face of presidential attacks, an understudied but politically salient topic. Scholars have long shown how political advocacy can protect bureaucracies from presidential attacks on policy regulation. We argue, however, that advocacy is insufficient to defend bureaucracies against attacks on policy implementation, which occurs largely outside the formal political arena. T…
Allocation of authority in European health policy
Perspectives in the study of the political economy of Covid‐19 vaccine regulation
Vaccines against SARS‐CoV‐2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID‐19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID‐19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commerci…
Dependency, Capacity, and Agency
Integrating Science, Technology and Health Policies in Brazil
Brazil has encouraged an ambitious set of policies towards the pharmaceutical industry, aiming to foster technological development while meeting health requirements. We characterise these efforts, labelled the 'Complexo Industrial da Saúde' (Health-Industry Complex, CIS), as an outcome of incremental policy change backed by the sustained efforts of public health professionals within the federal bureaucracy. As experts with a particular vision of …
Controlling Illegal Drugs
Syringe exchange programs in Brazil
The present study aims to evaluate the current operation of Brazilian syringe exchange programs (SEP). After consulting national and regional networks of people working in projects/ programs aiming to reduce drug-related harm, we identified 134 potential participant programs. Unfortunately, only 45 SEPs answered a survey, even after repeated attempts. The survey addressed: coverage, funding, procurement of basic supplies, managerial capacity, and…
Descentralização, Aids e redução de danos
O artigo avalia como a descentralização dos recursos e ações do Programa Nacional de DST e AIDS influenciou as transferências de recursos para os programas de prevenção ao HIV/AIDS entre usuários de drogas injetáveis no Rio de Janeiro, Brasil (1999-2006). Foram avaliados os efeitos da política de descentralização sobre as transferências de recursos para os Programas de Redução de Danos (PRD) no Rio de Janeiro. A descentralização das transferência…
Mobilizing Bias in Europe
What effects do interest groups have on the democratization and legitimacy of the European Union (EU)? Interest groups can democratize the EU only to the extent that they do not replicate inequalities. We use a newly constructed database to look for inequalities: Are the big organizations in Brussels the same as the ones in the EU member states? Are some member states' lobbies more active than others? And does the structure of EU lobbying create …
Allocation of authority in European health policy
Health Policy as Industrial Policy
In contrast to analyses that regard health policy and industrial policy as anathema to each other, either because an emphasis on health implies neglect of industry or because gains in industrialization come at the expense of health, we show positive synergies between the two realms. Government intervention into the health sector can catalyze interventions to promote industrial development in the pharmaceutical sector, which in turn can make healt…
Federalism, the Economic-Industrial Health Care Complex and High-Cost Pharmaceutical Assistance in Brazil
Brazil has a relevant, although relatively unknown, special medicines programme that distributes high-cost products, such as drugs needed for cancer treatments. In 2009, the purchase of these medicines became the responsibility of the Brazilian Federal Government. Until then, there were no clear norms regarding the responsibilities, in terms of the management/financing of these medicines, of the Brazilian Federal Government and of the states them…
Pharmaceutical Autonomy and Public Health in Latin America
"Pharmaceutical Autonomy and Public Health in Latin America: State, Society, and Industry in Brazil’s AIDS Program, By M. Flynn." The Journal of Development Studies, 52(12), pp. 1826–1827
How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health–industry complex in Brazil
The global health community is increasingly advocating for the local production of pharmaceuticals in developing countries as a way to promote technology transfer, capacity building and improve access to medicines. However, efforts to advance drug manufacturing in these countries revive an old dilemma of fostering technological development versus granting access to social services, such as healthcare. This paper explores the case of Brazil, a cou…
Promoting and regulating generic medicines
Promoting the use of generic drugs can constitute a core instrument for countries’ national pharmaceutical policies, one that reduces drug expenditure while expanding health care access. Despite the potential importance of such policy measures and the differences among national practices, scholars embarking on comparative analysis lack a roadmap for determining which dimensions of generic drug policy to assess and compare. This report fills that …
Building effective collaboration between health systems and the life sciences industry
This viewpoint reflects on the challenges of promoting affordable and innovative medicines while fostering a competitive environment for research and development in developing countries. We explore the life sciences industrial policies of Brazil and the United Kingdom in order to identify mechanisms and conditions that could serve as lessons to practitioners in other countries. We suggest three crucial design attributes: a strategic collaboration…
Integrating Science, Technology and Health Policies in Brazil
Brazil has encouraged an ambitious set of policies towards the pharmaceutical industry, aiming to foster technological development while meeting health requirements. We characterise these efforts, labelled the 'Complexo Industrial da Saúde' (Health-Industry Complex, CIS), as an outcome of incremental policy change backed by the sustained efforts of public health professionals within the federal bureaucracy. As experts with a particular vision of …
The comparative politics of Covid-19
COVID-19 has created a ramifying public health, economic, and political crisis throughout many countries in the world. While globally the pandemic is at different stages and far from under control in some countries, now is the time for public health researchers and political scientists to start understanding how and why governments responded the way they have, explore how effective these responses appear to be, and what lessons we can draw about …
Captura ou não captura? Perspectivas analíticas no estudo de políticas regulatórias
A discussão de captura regulatória não é uma agenda recente em estudos do Estado, mas o estabelecimento de critérios para identificação de captura, bem como a definição de protocolos para demonstração e mensuração do fenômeno estão longe de um consenso. O presente artigo tem por objetivo, por meio de uma revisão sistematizada não exaustiva da literatura, identificar as principais estratégias de captura e suas respectivas formas de mensuração. Pro…
Political discourse, denialism and leadership failure in Brazil’s response to Covid-19
The COVID-19 pandemic posed challenges for healthcare systems and political leaders across the globe. In this case study of Brazil, we argue that leadership failings at the highest level contributed to Brazil's relatively high and escalating death rates during 2020. Drawing on an analysis of a large amount of textual documentation drawn from media reports, we emphasise the role and consequences of President Jair Bolsonaro's political discourse an…
Social policy as an integral component of pandemic response
It is easy but mistaken to think that public health emergency measures and social policy can be separated. This paper compares the experiences of Brazil, Germany, India and the United States during their 2020 responses to the COVID-19 pandemic to show that social policies such as unemployment insurance, flat payments and short-time work are crucial to the effectiveness of non-pharmaceutical interventions as well as to their political sustainabili…
Coronavirus Politics
The politics of Covid-19 vaccination in middle-income countries
As the world struggles to meet the challenges of vaccination against COVID-19, more attention needs to be paid to issues faced by countries at different income levels. Middle-income countries (MICs) typically lack the resources and regulatory capacities to pursue strategies that wealthier countries do, but they also face different sets of challenges and opportunities than low-income countries (LICs). We focus on three dimensions of vaccination: p…
Perspectives in the study of the political economy of Covid‐19 vaccine regulation
Vaccines against SARS‐CoV‐2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID‐19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID‐19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commerci…
Real-world effectiveness of Covid-19 vaccines among Colombian adults
COVID-19 vaccines have been essential for reducing the impact of the pandemic; nevertheless, population-based data under real-life conditions are needed to compare their effectiveness in various contexts. The objective of this study was to estimate the effectiveness of vaccines in preventing hospitalization and death from COVID-19 in Colombia under real-life conditions among people aged 18 years and older, according to sex, age, confirmed history…
Provider-identified barriers to performance at seven Nigerian accident & emergency units
Background Nigeria hosts much of Africa’s morbidity and mortality from emergency medical conditions. We surveyed providers at seven Nigerian Accident & Emergency (A&E) units about (i) their unit’s ability to manage six major types of emergency medical condition (sentinel conditions) and (ii) barriers to performing key functions (signal functions) to manage sentinel conditions. Here, we present our analysis of provider-reported barriers to signal …
Dependency, Capacity, and Agency
State-Sponsored Activism
"State-Sponsored Activism: Bureaucrats and Social Movements in Democratic Brazil." The Journal of Development Studies, 56(7), pp. 1430–1431
Strengthening regulation for medical products in Tanzania
Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania’s pharmaceutical sector is often cited as a successful example of a well-functioning regulatory system in a developing country, attributed to the work of the Tanzania Food and Drugs Authority (TFDA), now the Tanzania Medicines and Medical Devices Authority (TMDA). This raises the quest…
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the problem remains unknown. We conducted a large field survey of essential medicines in Indonesia, and investigated how weighting survey results by market volume altered estimates of medicine quality. We …
Political science (23 works) · Medicine (20 works) · Economics (16 works) · Economic growth (13 works) · Business (12 works) · Law (12 works) · Politics (12 works) · Public Administration (11 works) · Health care (10 works) · Pharmaceutical Economics and Policy (9 works)